Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Otolaryngology – Head & Neck Surgery, |
RCV001375195 | SCV001571849 | pathogenic | Hearing impairment | 2021-04-12 | criteria provided, single submitter | clinical testing | PVS1_Strong, PS1_Moderate, PM2_Moderate |
Labcorp Genetics |
RCV001851648 | SCV002215337 | pathogenic | not provided | 2023-10-17 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu4*) in the BSND gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BSND are known to be pathogenic (PMID: 11687798). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with Bartter syndrome (PMID: 19646679). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4389). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002496257 | SCV002810362 | pathogenic | Bartter disease type 4A | 2022-04-29 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000004639 | SCV000024813 | pathogenic | Sensorineural deafness with mild renal dysfunction | 2009-08-01 | no assertion criteria provided | literature only |